Lu Man, Liu Hanqing, Zheng Bilian, Sun Shengrong, Chen Chuang
Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Cancers (Basel). 2022 Oct 19;14(20):5117. doi: 10.3390/cancers14205117.
Breast and thyroid glands are two common sites of female malignancies. Since the late 19th century, physicians have found that the cancers in either thyroid or mammary gland might increase the risk of second primary cancers in the other site. From then on, many observational clinical studies have confirmed the hypothesis and more than one theory has been developed to explain the phenomenon. Since the two glands both have secretory functions and are regulated by the hypothalamic-pituitary axis, they may share some common oncogenic molecular pathways. However, other risks factors, including medical interventions and hormones, are also observed to play a role. This article aims to provide a comprehensive review of the associations between the two cancers. The putative mechanisms, such as hormone alteration, autoimmune attack, genetic predisposition and other life-related factors are reviewed and discussed. Medical interventions, such as chemotherapy and radiotherapy, can also increase the risk of second primary cancers. This review will provide novel insights into the research designs, clinical managements and treatments of thyroid and breast cancer patients.
乳腺和甲状腺是女性恶性肿瘤的两个常见部位。自19世纪末以来,医生们发现甲状腺或乳腺的癌症可能会增加另一部位发生第二原发性癌症的风险。从那时起,许多观察性临床研究证实了这一假设,并提出了不止一种理论来解释这一现象。由于这两个腺体都具有分泌功能且受下丘脑 - 垂体轴调节,它们可能共享一些共同的致癌分子途径。然而,其他风险因素,包括医疗干预和激素,也被观察到起作用。本文旨在对这两种癌症之间的关联进行全面综述。对激素改变、自身免疫攻击、遗传易感性和其他生活相关因素等推定机制进行了综述和讨论。化疗和放疗等医疗干预也会增加第二原发性癌症的风险。本综述将为甲状腺和乳腺癌患者的研究设计、临床管理和治疗提供新的见解。